News

Progress and recognition

  1. Oct 2026

    Presented at IUVA Americas

    Sudhir Subramanya presented RadBox results in Halifax, Nova Scotia. ams OSRAM showcased RadBox with Lumaegis at the conference, and will show it again at electronica in Munich in November 2026.

  2. Aug 2026

    Next-generation RB-Z1 built

    Two units of the new RadBox design built and in testing, including handpiece temperature mapping.

  3. 2026

    Patent progress in the U.S. and Europe

    Notice of allowance in the U.S. and claims approved in Europe for the core light-and-heat technology.

  4. Aug 2026

    FDA concurs with RadBox test plan

    At Q-Submission meeting #5, the FDA concurred with the test organism panel and carriers for the De Novo submission, with clearance targeted Q2 2027.

  5. Sep 2025

    Pathway to FDA submission defined

    Hierarchy testing, lethality tests and full GLP validation agreed as the route to De Novo submission.

  6. 2025

    Plug and Play MedTech cohort and A-LIST finalist

    Lumaegis joined the Plug and Play MedTech cohort and was named an A-LIST finalist.

  7. Aug 2025

    Pre-seed funding to accelerate FDA De Novo

    Lumaegis secured pre-seed funding to accelerate its FDA De Novo submission.

    Read the release →
  8. Jul 2024

    FDA grants De Novo designation

    RadBox was granted De Novo designation by the FDA.

Recognition

Backed and recognized by

UT Austin Technology IncubatorPlug and Play MedtechDaybreak LabsIUVA RadLaunch awardeeA-LIST finalist 2025Showcased by ams OSRAM at IUVA Americas 2026 and electronica 2026, Munich

Follow Lumaegis on LinkedIn for the latest updates.